Literature DB >> 23516250

Amniotic membrane transplantation in treatment of persistent corneal ulceration after severe chemical and thermal eye injuries.

Stanislav A Iakimenko1, Oleksiy I Buznyk, Beata Rymgayllo-Jankowska.   

Abstract

PURPOSE: To analyze results of amniotic membrane transplantation (AMT) in treatment of corneal ulceration after severe chemical and thermal injuries.
METHODS: Analysis of 55 AMT in 53 patients (53 eyes) with corneal ulceration and limbal deficiency 180-360° of the limbus after grade 4-6 (Dua classification, 2001) chemical and thermal injuries was performed. Mean terms of the operation were 46.1 ± 46.4 days after the injury (range 8-181 days). Preoperative visual acuity (VA) was <0.01 in 33/53 patients (62.3%). Mean follow-up period was 8.8 ± 10.1 months (range 1.5-46 months).
RESULTS: Further corneal ulceration was prevented in 54/55 cases (98.1%), cornea epithelialized after 42/55 AMT (76.3%). Mean terms of corneal epithelialization were 24.2 ± 26.7 days after AMT (range 6-123 days). Corneal defect recurred in 3/42 successful cases (7.1%). Limbal deficiency of different extent with subsequent corneal conjunctivalization developed in all successful patients. The VA was ≥0.01 (range 0.01-1.0) in 23/42 patients (54.8%) with corneal epithelialization. The VA at the last visit was improved on 2 and more lines on the eye chart compared to preoperative VA in 15/42 patients with corneal epithelialization (35.7%), did not change in 18/42 successful patients (42.9%), and decreased on one line in 9/42 of these patients (26.2%). Symblepharon developed in 23/42 successful patients (54.7%).
CONCLUSIONS: Amniotic membrane transplantation may stop ulceration and promote corneal epithelialization in the majority of patients with the most severe chemical or thermal eye injuries in case of timely application of the operation and adequate fixation of the AMT graft.

Entities:  

Mesh:

Year:  2013        PMID: 23516250     DOI: 10.5301/ejo.5000243

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  5 in total

1.  Research on mouse model of grade II corneal alkali burn.

Authors:  Jun-Qiang Bai; Hai-Feng Qin; Shi-Hong Zhao
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

2.  Efficacy of self-retained cryopreserved amniotic membrane for treatment of neuropathic corneal pain.

Authors:  Melina I Morkin; Pedram Hamrah
Journal:  Ocul Surf       Date:  2017-10-13       Impact factor: 5.033

3.  Impact of adjuvant amniotic membrane transplantation in infectious ulcerative keratitis.

Authors:  Okyanus Bulut; Gunel Musayeva; Ozlem Barut Selver
Journal:  Int Ophthalmol       Date:  2022-09-07       Impact factor: 2.029

4.  Novel implantable composite biomaterial by fibrin glue and amniotic membrane for ocular surface reconstruction.

Authors:  Mingming Cai; Jie Zhang; Lili Guan; Min Zhao
Journal:  J Mater Sci Mater Med       Date:  2015-03-13       Impact factor: 3.896

5.  Current and Emerging Therapies for Limbal Stem Cell Deficiency.

Authors:  Abdelrahman M Elhusseiny; Mohammad Soleimani; Taher K Eleiwa; Reem H ElSheikh; Charles R Frank; Morteza Naderan; Ghasem Yazdanpanah; Mark I Rosenblatt; Ali R Djalilian
Journal:  Stem Cells Transl Med       Date:  2022-03-31       Impact factor: 6.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.